Literature DB >> 7781581

[Social adjustment and depression: value of the SAS-SR (Social Adjustment Scale Self-Report)].

S Achard1, J M Chignon, M F Poirier-Littré, A Galinowski, D Pringuey, J Van Os, F Lemonnier.   

Abstract

The Social Adjustment Scale Self-Report (SAS-SR) is a simple and inexpensive method, which allows the routine assessment of the patient's social adjustment, especially in the case of depression. Compared with other scales based on an interview with the patient, the SAS-SR is more sensitive to change in the patient's clinical status. The SAS-SR is a useful method as part of the detection of even mild depressions, regular aftercare evaluation of out-patients or as an outcome measure in longitudinal studies. A French version of the SAS-SR is now available and is currently under evaluation in a large-scale randomized therapeutic trial.

Entities:  

Mesh:

Year:  1995        PMID: 7781581

Source DB:  PubMed          Journal:  Encephale        ISSN: 0013-7006            Impact factor:   1.291


  3 in total

1.  Resolving a disagreement in a clinical team: overcoming conflicting views about the role of family therapy in an outpatient treatment programme for anorexia nervosa.

Authors:  N Godart; F Perdereau; Z Rein; F Curt; I Kaganski; R Lucet; M Corcos; J Fermanian; M Flament; P Jeammet
Journal:  Eat Weight Disord       Date:  2006-12       Impact factor: 4.652

2.  Social functioning in young people at risk for schizophrenia.

Authors:  Jacob S Ballon; Tejal Kaur; Iliana I Marks; Kristin S Cadenhead
Journal:  Psychiatry Res       Date:  2007-03-26       Impact factor: 3.222

3.  A dissonance-based intervention for women post roux-en-Y gastric bypass surgery aiming at improving quality of life and physical activity 24 months after surgery: study protocol for a randomized controlled trial.

Authors:  Fanny Sellberg; Sofie Possmark; Ata Ghaderi; Erik Näslund; Mikaela Willmer; Per Tynelius; Anders Thorell; Magnus Sundbom; Joanna Uddén; Eva Szabo; Daniel Berglind
Journal:  BMC Surg       Date:  2018-05-09       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.